Oxybutynin-associated esotropia

J AAPOS. 2007 Dec;11(6):624-5. doi: 10.1016/j.jaapos.2007.06.008.

Abstract

A 5-year-old girl with previously unrecognized hyperopia of approximately +3.00 D developed esotropia while being treated with oxybutynin for enuresis. The esotropia disappeared with cessation of oxybutynin and correction of her hyperopia. When the hyperopic correction was removed, she had a small esophoria. The esotropia was presumably triggered by the anticholinergic effect of oxybutynin, which reduced the ability to accommodate. The increased accommodative effort for vision generated an esotropia as a result of the accommodative convergence/accommodation ratio.

Publication types

  • Case Reports

MeSH terms

  • Accommodation, Ocular / drug effects
  • Child, Preschool
  • Convergence, Ocular / drug effects
  • Enuresis / drug therapy
  • Esotropia / chemically induced*
  • Female
  • Humans
  • Mandelic Acids / adverse effects*
  • Muscarinic Antagonists / adverse effects*

Substances

  • Mandelic Acids
  • Muscarinic Antagonists
  • oxybutynin